PF-4708671 inhibits S6K1, the most downstream kinase in the mTOR pathway, to inhibit BC cell migration in a triple-negative BC metastasis model and thus may provide an effective adjuvant treatment against BC metastasis (58). The gene discussed is MTOR; the disease is breast cancer.